Werner Sean, chief technology officer at Biolife, sells $7650 in shares

Published 22/10/2025, 22:10
Werner Sean, chief technology officer at Biolife, sells $7650 in shares

Sean Werner, chief technology officer of Biolife Solutions Inc (NASDAQ:BLFS), a $1.32 billion market cap company whose stock has gained nearly 25% over the past six months, sold 275 shares of common stock on October 20, 2025, according to a Form 4 filing with the Securities and Exchange Commission. The shares were sold at a price of $27.82, for a total transaction value of $7650.

Following the transaction, Werner directly owns 26037 shares of Biolife Solutions Inc.

The sale was executed under a Rule 10b5-1 trading plan, adopted on July 17, 2024, to cover tax obligations related to the vesting of restricted stock.

In other recent news, BioLife Solutions reported its second-quarter 2025 earnings, revealing a notable revenue increase of 29% year-over-year to $25.42 million, surpassing analysts’ expectations. Despite this positive revenue performance, the company posted a net loss of $15.8 million, or $0.33 per share, which was significantly larger than anticipated due to a $15.5 million in-process R&D expense related to the PanTHERA transaction. In a strategic move, BioLife Solutions sold its cold chain logistics subsidiary, SAVSU Cleo Technologies, to Peli BioThermal for $25.5 million in cash. Analyst firm KeyBanc reiterated its Overweight rating on BioLife Solutions, citing multiple growth avenues and a long-term revenue target exceeding $250 million by 2030. Additionally, H.C. Wainwright raised its price target for the company to $32 from $30, maintaining a Buy rating after the earnings announcement. Shareholders recently re-elected all seven director nominees and approved executive compensation and the appointment of Grant Thornton LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025. These developments reflect BioLife Solutions’ ongoing strategic efforts and investor confidence in its growth potential.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.